About Abhishek Bhuyan

Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.

Although Abhishek holds a bachelor's degree in science, his primary goal is to enhance his comprehension of self-learned investment research and provide valuable assistance to retail investors, enabling them to make informed investment decisions.


Recent Articles By Abhishek Bhuyan

: JNJ |  News, Ratings, and Charts

3 Blue-Chip Stocks to Buy and Hold Forever

Amidst market uncertainty, blue-chip stocks provide stability, diversification, and reliable returns. Therefore, Johnson & Johnson (JNJ), International Business Machines (IBM), and AT&T (T) could be wise picks to buy and hold forever for smart investors. Read on...
: INTU |  News, Ratings, and Charts

3 Cloud Computing Stocks Leading the Digital Transformation

Cloud computing drives market growth and digital transformation by streamlining operations with AI, storage, and database services, boosting the software applications market. Amid this backdrop, investors could consider buying cloud computing stocks, Intuit (INTU), Autodesk (ADSK), and Workday (WDAY) leading digital transformation. Read more...
: BOX |  News, Ratings, and Charts

Why These 2 Technology Services Stocks Are Perfect for Your Portfolio

The tech services sector's bright prospects are driven by rising investments in digital transformation and AI, alongside evolving tech needs. Hence, let's explore why tech stocks like NetScout Systems (NTCT) and Box (BOX) are perfect additions to your portfolio...
: XLU |  News, Ratings, and Charts

3 Top Utility ETFs for Defensive Investing

Amid potential market volatility, investors seeking defensive options may consider robust utility ETFs like iShares U.S. Utilities (IDU), Vanguard Utilities Index Fund (VPU), and The Utilities Select Sector SPDR (XLU) for their relatively stable nature and steady dividends. Read more...
: TENB |  News, Ratings, and Charts

3 Cybersecurity Stocks With Upbeat Q2 Earnings Outlook

The cybersecurity sector is well-positioned for strong growth due to increased digitization, cloud adoption, rising cyber threats, and regulatory efforts. Therefore, investors should consider buying robust cybersecurity stocks like Tenable Holdings (TENB), Clear Secure (YOU), and Radware (RDWR) with an upbeat Q2 earnings outlook. Read more...
: VIAV |  News, Ratings, and Charts

3 Growth Stocks Under $10 You Should Own

With a stable global economic growth outlook and easing U.S. inflation, investing in growth stocks like Viavi Solutions (VIAV), Coursera (COUR), and MiMedx Group (MDXG) could be wise. These stocks boast solid fundamentals and significant growth potential for investors seeking opportunities under $10. Read on...
: ABT |  News, Ratings, and Charts

3 Healthcare Stocks Set to Benefit From Aging Population Trends

The healthcare industry is set to grow significantly due to technological advances, an aging population, and increasing demand for quality healthcare. To that end, it could be wise to buy fundamentally strong healthcare stocks like Abbott Laboratories (ABT), Stryker (SYK), and Centene (CNC), which are set to benefit from these trends. Read more...
: STZHF |  News, Ratings, and Charts

3 High-Growth Steel Stocks for Smart Investors

The steel industry is set for growth with strong demand from the manufacturing, housing, automobile, and machinery sectors. Smart investors might consider high-growth steel stocks like Mesabi Trust (MSB), Friedman Industries (FRD), and Stelco Holdings (STZHF). Read on...
: SMAR |  News, Ratings, and Charts

3 Tech Stocks With Strong Earnings Growth Forecast for Q2

The tech sector is expanding thanks to digitization across industries, increased tech spending, a focus on customer preferences, and the demand for automated management solutions. Therefore, tech stocks with strong earnings growth forecasts for Q2 like Smartsheet (SMAR), Blackbaud (BLKB), and Box (BOX) could be ideal additions to one’s portfolio. Read on...
: ACAD |  News, Ratings, and Charts

3 Mid-Cap Stocks Analysts Believe Will Soar 50% or More

The blend of growth potential and stability in mid-cap pharma stocks is driven by rising demand for innovative therapies, strong economic conditions, and technological advancements that boost the sector's growth trajectory. Therefore, considering strong mid-cap stocks like Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and ACADIA Pharmaceuticals (ACAD), expected to soar 50% or more, could be wise. Keep reading...
Page generated in 1.4165 seconds.